End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
148.3 USD | 0.00% | 0.00% | -6.76% |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |